Mahmoodkhani Mehdi, Behfarnia Parham, Aminmansour Bahram
Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2024 Apr 27;13:35. doi: 10.4103/abr.abr_453_23. eCollection 2024.
Given the dearth of extensive research comparing the Glasgow Coma Scale with the Rotterdam scoring system for predicting mortality in trauma patients, this study was conducted to determine which scale provides a more realistic prediction of mortality in trauma patients after three months.
This observational study was performed at Kashani Hospital in Isfahan, Iran. Patients with TBI who were admitted between February 2022 and February 2023 were included in the study. Approval from the Ethical Committee of Isfahan University of Medical Sciences was obtained prior to conducting this study.
We included 152 adult patients who completed the GOS-E and the QOLIBRI-OS three-month post-injury. The median age was 35 years (IQR = 17-70). Most patients 139 (91.4%) were classified as having a severe TBI.
The results of the present study showed that both the use of GCS and Rotterdam CT scores can be effective in predicting the three-month mortality and QOLIBRI-OS scores of patients, with the difference that the predictive power of the three-month Rotterdam CT score is greater than that of the GCS.
鉴于在比较格拉斯哥昏迷量表与鹿特丹评分系统对创伤患者死亡率预测方面缺乏广泛研究，本研究旨在确定哪种量表能更准确地预测创伤患者三个月后的死亡率。
本观察性研究在伊朗伊斯法罕的卡沙尼医院进行。纳入2022年2月至2023年2月期间收治的创伤性脑损伤患者。在开展本研究前获得了伊斯法罕医科大学伦理委员会的批准。
我们纳入了152例成年患者，他们在受伤三个月后完成了扩展格拉斯哥预后量表（GOS-E）和脑损伤后生活质量量表（QOLIBRI-OS）评估。中位年龄为35岁（四分位间距 = 17 - 70）。大多数患者139例（91.4%）被归类为重度创伤性脑损伤。
本研究结果表明，格拉斯哥昏迷量表（GCS）和鹿特丹CT评分在预测患者三个月死亡率和QOLIBRI-OS评分方面均有效，不同之处在于鹿特丹CT评分三个月的预测能力大于格拉斯哥昏迷量表。
